Company Respirerx Pharmaceuticals Inc Other OTC
Equities
US2205243007
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Arnold Lippa
CEO | Chief Executive Officer | 77 | 22/13/22 |
Jeff Margolis
DFI | Director of Finance/CFO | 68 | 22/13/22 |
Richard Purcell
CTO | Chief Tech/Sci/R&D Officer | 63 | 15/14/15 |
David Dickason
PRN | Corporate Officer/Principal | - | 15/20/15 |
Marc M. Radin
AUD | Comptroller/Controller/Auditor | - | 01/13/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Arnold Lippa
CEO | Chief Executive Officer | 77 | 22/13/22 |
Director/Board Member | - | 22/23/22 | |
Jeff Margolis
DFI | Director of Finance/CFO | 68 | 22/13/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 365,418,647 | 341,184,734 ( 93.37 %) | 0 | 93.37 % |
Stock B | 0 | 37,500 | 0 | 0 |
Company contact information
RespireRx Pharmaceuticals, Inc.
126 Valley Road Suite C
07452, Glen Rock
+201 444 4947
http://www.respirerx.comSector
1st Jan change | Capi. | |
---|---|---|
+8.63% | 114B | |
+13.17% | 107B | |
-12.76% | 22.22B | |
-2.53% | 21.28B | |
-7.19% | 17.51B | |
-39.93% | 17.17B | |
+6.67% | 14.14B | |
+33.90% | 12.2B | |
-28.60% | 7.83B |
- Stock Market
- Equities
- RSPI Stock
- Stock
- Company Respirerx Pharmaceuticals Inc